How eating timing affects metabolism and liver health
Part of Digestive system, Hormones & metabolism clinical trials.
This study looks at how the timing of meals throughout the day affects your metabolism and health. It involves tracking your eating patterns and answering health questions using your phone or computer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18–80 (or 18–50 if you're a new mother)
- Access to a smartphone or computer to log your meals and answer surveys
- No active smoking, heavy alcohol use, or recreational drug use
- Not taking weight-loss or appetite-changing medications (like GLP-1 drugs or certain antidepressants)
- Not a shift worker with irregular sleep schedules
- No major organ disease (except type 2 diabetes or heart disease if you have fatty liver disease)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at a new non-invasive screening method to predict metabolic dysfunction–associated steatotic liver disease (MASLD), a condition where fat builds up in the liver. The goal is to help identify people who may be at risk without needing invasive tests.
This study tests if restricting eating to daytime hours for 12 weeks can reduce liver fat in people with obesity. It aims to help those with fatty liver disease improve their health without medication.
This study tests whether changing when you eat (timing your meals) can improve fatty liver disease. You might be eligible if you have a certain body mass index and eat over 14 hours a day.
This study looks at whether the natural chemicals made by your gut bacteria from the food you eat could affect liver fat and health. If you have MASLD (a fatty liver condition), researchers want to measure these gut-produced substances to better understand the disease.
This research studies fatty liver disease linked to metabolic problems like diabetes and obesity. You'll wear a fitness tracker and have liver imaging to help doctors understand the disease and find new treatments.
This study is testing whether advanced imaging and other non-invasive methods can properly identify people with significant liver scarring due to metabolic liver disease or alcohol-related liver disease. It may help find better ways to track liver health without repeated needle biopsies.
Hear when a new MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.